Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Year End 2014 Financial Results 12/17/14 Eagle Pharmaceuticals to Discuss 2014 Fourth Quarter and Year-End Financial Results on December 17, 2014 12/4/14 Eagle Pharmaceuticals to Present at Piper Jaffray 2014 Healthcare Conference 11/20/14 Eagle Pharmaceuticals Reports Positive Outcomes from Clinical Trial of Bendamustine HCl Product Delivered via Low-Volume, Rapidly Infused Admixture 11/10/14 Eagle Pharmaceuticals to Present at Stifel 2014 Healthcare Conference 11/7/14 Eagle Pharmaceuticals to Present at 21st Annual NewsMakers in the Biotechnology Industry Investment Conference 9/23/14 Eagle Pharmaceuticals Announces That Teva Requests a Motion to Dismiss with Prejudice in Its Bendamustine Patent Infringement Lawsuit 9/17/14 Eagle Pharmaceuticals, Inc. Reports Third Quarter 2014 Results 8/11/14 Eagle Pharmaceuticals Schedules Third Quarter Earnings Release and Conference Call 7/30/14 FDA Approves Eagle Pharmaceuticals’ Ryanodex® for the Treatment of Malignant Hyperthermia 7/23/2014 7/23/14 Pagination Current page 1 Page 2 Next page Last page
